Archives for the 'news2' Category
Revenues at CryoLife rose 21% to $26.8 million in the third quarter of 2008. Net income was $3.6 million, or $0.13 per share, compared to $1.9 million, or $0.07 per share in Q3 2007.
Tissue processing […]
5 November 2008 |
Blog, Member Spotlight, news2 |
NxStage Medical may be losing steam. The maker of dialysis products reported third quarter revenues of $30.5 million, a slight decrease from the $31.6 million reported last quarter.
While revenues in the company’s home dialysis business […]
3 November 2008 |
Blog, news2 |
Third quarter revenues at Clarient increased 59% to $19.0 million from the $11.9 million reported in Q3 2007. This marks the company’s 17th consecutive quarter of sequential revenue growth. Higher testing volume, a favorable service […]
30 October 2008 |
Blog, Member Spotlight, news2 |
When an athlete is injured, their career and value to the team are at risk. At all levels of athletics, including everyday fitness enthusiasts, the frequency and severity of injuries makes it imperative to find […]
29 October 2008 |
Blog, news2, Video |
Only months after Langer sold its Bi-Op subsidiary for less than its purchase price, the company announced the sale of its custom orthotics business to The Orthotic Group (TOG), a manufacturer of prescription custom foot […]
27 October 2008 |
Blog, news2, feature2 |
A German Federal Court has found that CoreValve’s ReValving system (for transcatheter aortic valve replacement) does not infringe any of the claims of the Andersen patent held by Edwards Lifesciences. That patent relates to the […]
20 October 2008 |
Blog, news2 |
The New York-based hedge fund, Elliott Associates, has offered to buy all of the outstanding shares of Endologix for $98 million or $2.25 per share. The unsolicited proposal came yesterday. Endologix stock, which had hovering […]
17 October 2008 |
Blog, news2 |
An infusion of capital will help NeoChord go the distance. Previously, the company had raised $1.76 million from angel investors in a convertible debt offering. Clarian Health Ventures, an Indiana-based fund, made the investment. The […]
15 October 2008 |
Blog, Member Spotlight, news2, feature2 |
In the midst of this credit crisis, having access to capital at favorable rates will make or break many of the smaller device firms we cover.
It’s reassuring to see companies with strong balance sheets and […]
13 October 2008 |
Blog, news2 |
A Texas jury has found that Palomar’s products do not infringe on a Candela patent.
Candela had accused eight Palomar handpieces of infringing on three Candela Patents. Curiously, just days before the start of trial, Candela […]
10 October 2008 |
Blog, news2, feature2 |
